Markel Group’s Merck MRK Stock Holding History

Markel Group’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-5,869	Closed	-$305K	–	145
2018 Q1	$305K	Hold	5,869	–	–	0.01%	134
2017 Q4	$315K	Hold	5,869	–	–	0.01%	135
2017 Q3	$359K	Hold	5,869	–	–	0.01%	135
2017 Q2	$359K	Hold	5,869	–	–	0.01%	133
2017 Q1	$356K	Hold	5,869	–	–	0.01%	130
2016 Q4	$330K	Hold	5,869	–	–	0.01%	129
2016 Q3	$349K	Hold	5,869	–	–	0.01%	125
2016 Q2	$323K	Buy	+5,869	New	+$312K	0.01%	127

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Markel Group's MRK Position: Q2 2018 in Review

Markel Group sold out of Merck (MRK) in Q2 2018, closing a stake of 5,869 shares — an estimated $305K sold.

Markel Group first reported a position in MRK in Q2 2016 and held it in 8 quarters. The position peaked at $359K in Q3 2017. 2,017 funds tracked by Wall St. Rank hold MRK as of Q2 2018.

Markel Group reported no remaining Merck position as of Q2 2018 after selling out during the quarter.
Markel Group sold 5,869 Merck shares in Q2 2018, an estimated $305K.
Markel Group first reported a position in Merck in Q2 2016 and held it in 8 quarters.
Markel Group's Merck position peaked at $359K in Q3 2017.
2,017 funds tracked by Wall St. Rank held Merck as of Q2 2018.

Based on Markel Group's 13F filing for Q2 2018, filed 3 Aug 2018.